oasis 1 semaglutide First oral made a strong impression in OASIS-1 #obesity with 15% #weightloss now orforglipron leads the impressive pack of new small molecule oral GLP-1RA with robust #Weightloss and good tolerability ADA2023 ECO 2026 - Early Responders

Retatrutide targets three hormone receptorsGLP-1, GIP, and glucagonwhile semaglutide only targets GLP-1

The mechanism is straightforward: GLP-1 receptor agonists reduce post-meal fat absorption, decrease liver fat production, and improve insulin sensitivity, all of which drive triglyceride levels down

Food , 21 (3), 269273

When Mod GRF 1-29 binds to these receptors, it activates a signaling cascade within the anterior pituitary gland

What is semaglutide Semaglutide, the active ingredient in Novo Nordisks GLP-1 drugsOzempic, Wegovy and Rybelsuswas originally developed for type-2 diabetes and later approved for obesity treatment, with studies showing patients could lose 15-23% of body weight

J Neuroophthalmol (2014) 34:17785.10.1097/wno.0000000000000132 115 HiromatsuYYangDBednarczukTMiyakeINonakaKInoueY